These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 22410026

  • 1. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [Abstract] [Full Text] [Related]

  • 2. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 3. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 4. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 6. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS, Chen TH, Jeng LB, Yang HR, Li PC, Lee CC, Yeh CC, Lai HC, Su WP, Peng CY, Chen YF, Ho YJ, Tsai PP.
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [Abstract] [Full Text] [Related]

  • 7. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 8. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK.
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [Abstract] [Full Text] [Related]

  • 9. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD, Choi JY, Kwon JH, Jang JW, Bae SH, Yoon SK, You YK, Kim DG.
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [Abstract] [Full Text] [Related]

  • 10. MELD and prediction of post-liver transplantation survival.
    Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, Eghtesad B, Marcos A, Shakil AO.
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [Abstract] [Full Text] [Related]

  • 11. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [Abstract] [Full Text] [Related]

  • 12. Right-liver living donor transplantation for decompensated end-stage liver disease.
    Testa G, Malagó M, Nadalin S, Hertl M, Lang H, Frilling A, Broelsch CE.
    Liver Transpl; 2002 Apr; 8(4):340-6. PubMed ID: 11965577
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 14. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [Abstract] [Full Text] [Related]

  • 15. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.
    Suzuki H, Bartlett AS, Muiesan P, Jassem W, Rela M, Heaton N.
    Transplant Proc; 2012 Mar; 44(2):384-8. PubMed ID: 22410023
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [Abstract] [Full Text] [Related]

  • 17. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodríguez-Canete A, Gonzalez-Sanchez A.
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [Abstract] [Full Text] [Related]

  • 18. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation.
    Akyildiz M, Karasu Z, Arikan C, Kilic M, Zeytunlu M, Gunsar F, Ersoz G, Akarca U, Batur Y, Tokat Y.
    Transplant Proc; 2004 Jun; 36(5):1442-4. PubMed ID: 15251354
    [Abstract] [Full Text] [Related]

  • 19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N.
    Clin Transpl; 2011 Jun; ():223-35. PubMed ID: 22755416
    [Abstract] [Full Text] [Related]

  • 20. Impact of preoperative serum sodium concentration in living donor liver transplantation.
    Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y.
    J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.